David Ju - Burcon NutraScience Independent Director
| BU Stock | CAD 0.09 0.01 5.56% |
Director
Mr. David Ju is Independent Director of the Company. Mr. Ju is a vicepresident of Concord Pacific Group, a Canadian multiindustry investment group with a diverse portfolio of businesses in Canada, the United Kingdom and Hong Kong. Mr. Ju has extensive experience in financial services and largescale real estate development projects in both the U.S. and Canada. A chartered accountant by training, Mr. Ju was a former member of PricewaterhouseCoopers in Vancouver and New York, where he consulted on transactions and advised on corporate governance and assurance matters, including compliance with the Sarbanes Oxley Act 404 for clients listed on both the Toronto Stock Exchange as well as the New York Stock Exchange since 2017.
| Tenure | 7 years |
| Address | 1946 West Broadway, Vancouver, BC, Canada, V6J 1Z2 |
| Phone | 604 733 0896 |
| Web | https://www.burcon.ca |
Burcon NutraScience Management Efficiency
The company has return on total asset (ROA) of (0.3922) % which means that it has lost $0.3922 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5936) %, meaning that it generated substantial loss on money invested by shareholders. Burcon NutraScience's management efficiency ratios could be used to measure how well Burcon NutraScience manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of December 2024, Return On Tangible Assets is likely to drop to -0.67. In addition to that, Return On Capital Employed is likely to drop to -0.64. At this time, Burcon NutraScience's Non Currrent Assets Other are very stable compared to the past year. As of the 11th of December 2024, Other Current Assets is likely to grow to about 826.5 K, while Total Assets are likely to drop about 10.9 M.Similar Executives
| Found 5 records | DIRECTOR Age | ||
| Barry Reiter | Baylin Technologies | 65 | |
| Ephraim Ulmer | Baylin Technologies | 46 | |
| Douglas Jones | Baylin Technologies | 76 | |
| Donald Simmonds | Baylin Technologies | 58 | |
| Harold Wolkin | Baylin Technologies | 65 | |
Management Performance
| Return On Equity | -1.59 | ||||
| Return On Asset | -0.39 |
Burcon NutraScience Leadership Team
Elected by the shareholders, the Burcon NutraScience's board of directors comprises two types of representatives: Burcon NutraScience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Burcon. The board's role is to monitor Burcon NutraScience's management team and ensure that shareholders' interests are well served. Burcon NutraScience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Burcon NutraScience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randy Willardsen, Senior Vice President - Process | ||
| Johann Tergesen, President, Chief Executive Officer, Chief Operating Officer | ||
| Paul Lam, Director Relations | ||
| Kip MBA, Chief Officer | ||
| Dorothy Law, Senior Vice President - Legal, Corporate Secretary | ||
| Peter Kappel, Independent Director | ||
| Alan Chan, Independent Director | ||
| Debora Fang, Independent Director | ||
| MBA CFA, Chief Officer | ||
| Bradford Allen, Lead Independent Director | ||
| David Ju, Independent Director | ||
| Chi Ng, Director | ||
| John Gilpin, Independent Director | ||
| Martin Schweizer, Vice President - Technical Development | ||
| Kam Law, Senior Secretary | ||
| Rosanna Chau, Director | ||
| David Tyrrell, Independent Chairman of the Board | ||
| Jade Cheng, Chief Financial Officer, Treasurer | ||
| Calvin Ng, Director |
Burcon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Burcon NutraScience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.59 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (7.45) % | ||||
| Current Valuation | 16.37 M | ||||
| Shares Outstanding | 172.48 M | ||||
| Shares Owned By Insiders | 28.06 % | ||||
| Shares Owned By Institutions | 0.21 % | ||||
| Number Of Shares Shorted | 110.56 K | ||||
| Price To Earning | (5.20) X | ||||
| Price To Book | 2.53 X |
Other Information on Investing in Burcon Stock
Burcon NutraScience financial ratios help investors to determine whether Burcon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Burcon with respect to the benefits of owning Burcon NutraScience security.